Research Operations
UW Carbone Cancer Center Improves CCSG Data Management Processes with EVAL
Renewing a Cancer Center Support Grant (CCSG) is a complicated process. In order to demonstrate value to the NCI, organizations need to showcase the impact of their research in the cancer center and beyond. Collecting, analyzing, and reporting on this data is often an inefficient and labor-intensive process, requiring a large amount of dedicated staff time and resources.
Indiana University Melvin and Bren Simon Cancer Center Sees 52% Time Savings with Advarra Participant Payments
With an increasing number of clinical trials conducted each year, IU’s Simon Cancer Center searched for a system that would decrease clinical staff’s time spent paying study participants and reduce inefficient workflows and associated costs.
A Tale of Two Sites: The Power of Integrated Research Administration
Learn how institutions attract more studies from the the tale of two sites: one with an integrated research administration, and one without.
Quality Improvement Project vs Human Subject Research: What’s the Difference?
Quality improvement and human subjects research often intersect. Executive IRB Chair Sara Harnish discusses questions to differentiate the two.
The Future of Phase I Oncology Studies
Oncology drugs in phase I trials are usually conducted on patients with cancer due to their inherent risk. Advarra IRB member Ran Goldman expands:
Meeting the Challenges of Investigator-Initiated Trials
How does investigator-initiated research differ from other types of clinical research? Advarra IRB Chairperson Robert Romanchuk explains.
Survey Best Practices for Process Improvement
Learn best practices of survey creation to help measure process improvement among stakeholders at an organization.
EVAL Case Study with Case Comprehensive Cancer Center
As the Case Comprehensive Cancer Center approached their recent CCSG renewal, their team recognized they needed a better system to store and analyze CCSG requirements, including grants, publications, investigators, pilots, and more.
Infection Control and Biosafety in Gene Therapy Research
Given the growth in gene therapy research, sponsors, CROs and sites have become increasingly curious about the requirements to be able to conduct such studies.
ICH-GCP Guidelines and Research Conducted in the US
Learn the basics of how ICH-GCP Guidelines can impact the study ICF and how we at Advarra came to our updated policy on the topic.
What’s the Difference Between Right to Try and Expanded Access?
Let’s take a look at the basics of what each program does and does not do for patients seeking to access investigational therapies.
Karmanos Cancer Institute Unites Operational Teams and Creates Optimized Processes
Team members at the Barbara Ann Karmanos Cancer Institute recognized the importance of operational efficiency, and investigated ways they could gather and present operational data they had already collected to identify areas of success and opportunities for growth.